The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 TrialAlison M. Schram, Justin Meyerowitz, Eric B. Haura et al.|Clinical Cancer Research|2025Cited by 7